Literature DB >> 2688872

Effects of periodic administration of Nocardia rubra cell-wall skeleton on immunoglobulin production and B-cell-stimulatory factor activity in vitro in workers at a poison gas factory.

S Hozawa1, S Ishioka, J Yanagida, M Takaishi, S Matsuzaka, M Ohsaki, M Yamakido.   

Abstract

The former workers at the Okunojima poison gas factory (poison gas workers) are a high-risk group for malignant neoplasms and show abnormalities in cellular immunity. At the same time, poison gas workers often have chronic respiratory diseases, such as chronic bronchitis, and are highly susceptible to respiratory infections. To explore the possibility of immunological cancer prevention, we have periodically administered 200 micrograms Nocardia rubra cell-wall skeleton (N-CWS) to poison gas workers once every 3 months since December 1978. During this period, we noted a significantly lower incidence of influenza among poison gas workers receiving N-CWS than in those not receiving the drug during the influenza epidemic. This finding suggested that the administration of N-CWS enhanced the resistance of these workers to infections. Therefore, periodical administration of N-CWS to poison gas workers was considered to enhance the reduced T-cell function of normalizing antibody production by stimulating the production of B-cell-stimulatory factor (BSF). In the present study, to clarify the mechanism of immunosuppression in the poison gas workers and to examine the effects of continual administration of N-CWS on this condition, we compared the immunoglobulin production and the proliferative and differentiative activities of B-cell-stimulatory factor (BSF) of peripheral blood mononuclear cells (PBMC), in poison gas workers treated or not treated with N-CWS. Comparisons were also made with age-matched healthy controls. In the untreated poison gas workers, immunoglobulin and BSF production of PBMC were reduced as compared with the control group. On the other hand, in the poison gas workers receiving N-CWS, immunoglobulin and BSF production of PBMC were restored nearly to the control level. These results show that in vitro antibody production in the poison gas workers was reduced and that a reduction in BSF production of T cells was one of its causes.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2688872     DOI: 10.1007/bf01669429

Source DB:  PubMed          Journal:  Cancer Immunol Immunother        ISSN: 0340-7004            Impact factor:   6.968


  21 in total

1.  Immune functions of former poison gas workers. I. Mitogenic response of lymphocytes and serum factors.

Authors:  M Yamakido; J Yanagida; S Ishioka; S Matsuzaka; S Hozawa; M Takaishi; T Inamizu; M Akiyama; Y Nishimoto
Journal:  Hiroshima J Med Sci       Date:  1986-06

2.  Biologically active components from mycobacterial cell walls. I. Isolation and composition of cell wall skeleton and component P3.

Authors:  I Azuma; E E Ribi; T J Meyer; B Zbar
Journal:  J Natl Cancer Inst       Date:  1974-01       Impact factor: 13.506

3.  Adjuvant activity of mycobacterial fractions. II. In vitro adjuvant activity of cell walls of mycobacteria, nocardia and corynebacteria.

Authors:  T Taniyama; T Watanabe; I Azuma; Y Yamamura
Journal:  Jpn J Microbiol       Date:  1974-11

4.  Mustard gas as a cause of respiratory neoplasia in man.

Authors:  S Wada; M Miyanishi; Y Nishimoto; S Kambe; R W Miller
Journal:  Lancet       Date:  1968-06-01       Impact factor: 79.321

5.  T cell growth factor: parameters of production and a quantitative microassay for activity.

Authors:  S Gillis; M M Ferm; W Ou; K A Smith
Journal:  J Immunol       Date:  1978-06       Impact factor: 5.422

6.  Changes in natural killer cell, antibody-dependent cell-mediated cytotoxicity and interferon activities with administration of Nocardia rubra cell wall skeleton to subjects with high risk of lung cancer.

Authors:  M Yamakido; S Ishioka; K Onari; S Matsuzaka; J Yanagida; Y Nishimoto
Journal:  Gan       Date:  1983-12

7.  Interleukin 2 receptors on human B cells. Implications for the role of interleukin 2 in human B cell function.

Authors:  A Muraguchi; J H Kehrl; D L Longo; D J Volkman; K A Smith; A S Fauci
Journal:  J Exp Med       Date:  1985-01-01       Impact factor: 14.307

8.  Mechanism(s) of in vitro macrophage activation with Nocardia rubra cell wall skeleton: the effects on macrophage activating factor production by lymphocytes.

Authors:  T Masuno; S Hayashi; M Ito; T Ikeda; T Ogura; S Kishimoto; Y Yamamura
Journal:  Cancer Immunol Immunother       Date:  1986       Impact factor: 6.968

9.  B cell growth factor and T cell growth factor produced by mitogen-stimulated normal human peripheral blood T lymphocytes are distinct molecules.

Authors:  A Muraguchi; T Kasahara; J J Oppenheim; A S Fauci
Journal:  J Immunol       Date:  1982-12       Impact factor: 5.422

10.  Differential sensitivity of human B cell subsets to activation signals delivered by anti-mu antibody and proliferative signals delivered by a monoclonal B cell growth factor.

Authors:  A Muraguchi; J L Butler; J H Kehrl; A S Fauci
Journal:  J Exp Med       Date:  1983-02-01       Impact factor: 14.307

View more
  3 in total

1.  Effect of Nocardia rubra cell-wall skeleton on cancer prevention in humans.

Authors:  M Yamakido; S Ishioka; S Hozawa; S Matsuzaka; J Yanagida; T Shigenobu; M Otake; Y Nishimoto
Journal:  Cancer Immunol Immunother       Date:  1992       Impact factor: 6.968

2.  Nocardia rubra cell wall skeleton accelerates cutaneous wound healing by enhancing macrophage activation and angiogenesis.

Authors:  Yi Wang; Ying Hu; Ben Ma; Fei Wang; Sheng Liu; Jing Xu; Xu-Lin Chen; Xiong-Wen Lü
Journal:  J Int Med Res       Date:  2018-04-18       Impact factor: 1.671

3.  Nocardia Rubra Cell Wall Skeleton Up-Regulates T Cell Subsets and Inhibits PD-1/PD-L1 Pathway to Promote Local Immune Status of Patients With High-Risk Human Papillomavirus Infection and Cervical Intraepithelial Neoplasia.

Authors:  Wei Chen; Yi Zhang; Chunfang Zhao; Suxia Shao; Yanan Zhang; Xuehui Li; Xue Bai; Qianyu Guo; Qianwen Liu; Junmin Tang; Lei Zhang
Journal:  Front Immunol       Date:  2021-01-20       Impact factor: 7.561

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.